A factual guide to one of the most-studied mushroom extracts in the world — what AHCC is, how it's made, what the research says, and what to look for when buying AHCC capsules in the UK.
📋 In This Guide
What Is AHCC? How AHCC Is Made What's Inside AHCC? Composition and Structure AHCC vs Other Mushroom Extracts What Does the Research Say? AHCC Dosage: What Do Studies Use? Side Effects and Safety Profile Potential Drug Interactions What to Look for When Buying AHCC in the UK PURETREX AHCC Products Frequently Asked Questions
What Is AHCC?
AHCC stands for Active Hexose Correlated Compound. It is a proprietary nutritional supplement derived from the mycelia — the root-like filaments — of the shiitake mushroom (Lentinula edodes). Shiitake is one of the most widely consumed edible mushrooms worldwide and has a long history of use in traditional East Asian cuisine and herbal practice.
AHCC was originally developed in 1989 at the University of Tokyo's Faculty of Pharmaceutical Sciences in collaboration with Amino Up Co., Ltd., a Japanese company based in Sapporo, Hokkaido. The compound was initially created as part of research into natural products, though it has since become one of the most extensively studied mushroom-derived supplements globally.
Today, AHCC is used as a dietary supplement in over 40 countries and has been the subject of more than 30 human clinical studies and over 100 preclinical (laboratory and animal) studies. Its use is most established in Japan and the United States. In Japan, it is reported to be the second most popular complementary supplement among individuals undergoing cancer treatment, behind Agaricus blazei.
AHCC is classified as a food supplement in the UK and is not a medicine. It is not intended to diagnose, treat, cure, or prevent any disease.
How AHCC Is Made
What sets AHCC apart from standard shiitake mushroom powders and extracts is its unique manufacturing process. Rather than simply grinding or extracting the fruiting body (the visible mushroom cap and stem), AHCC is produced from the mycelia — the underground network of thread-like structures that form the base of the mushroom organism.
Cultivation
Selected strains of shiitake mycelia are cultured in a liquid medium for 45–60 days. The mycelia proliferate and form globular fungal bodies rather than fruiting bodies.
Enzymatic Decomposition
The cultured mycelia undergo enzymatic breakdown, reducing polysaccharide molecule size. This produces the low-molecular-weight alpha-glucans characteristic of AHCC.
Sterilisation
The material is sterilised to ensure microbiological safety and eliminate any potential contaminants from the culturing process.
Concentration & Freeze-Drying
The extract is concentrated and freeze-dried into a powder, which can be encapsulated or used in liquid formulations for supplementation.
This patented process is what distinguishes genuine AHCC from generic shiitake extracts. The extended culturing and enzymatic steps produce a distinct polysaccharide profile — specifically, a high concentration of low-molecular-weight alpha-glucans — which is not found in standard mushroom products.
What's Inside AHCC? Composition and Structure
The composition of AHCC is dominated by oligosaccharides, which make up approximately 74% of its dry weight. Within this oligosaccharide fraction, around 20% consists of partially acylated alpha-1,4-glucans, which have a relatively low mean molecular weight of approximately 5,000 Daltons.
This is noteworthy because most other medicinal mushroom extracts are rich in beta-glucans with much higher molecular weights (typically 100,000 to 500,000 Daltons). The low molecular weight of AHCC's alpha-glucans is thought to allow for better intestinal absorption compared to the larger beta-glucan molecules found in other mushroom supplements.
📄 AHCC Composition Breakdown
Oligosaccharides: ~74% of dry weight (including partially acylated alpha-1,4-glucans at ~5,000 Daltons)
Beta-glucans: Smaller fraction than alpha-glucans
Amino acids: Present in trace amounts
Minerals and lipids: Present as minor components
The partially acylated alpha-glucan fraction is unique to AHCC and is produced specifically through its patented manufacturing process. This compound is not present in raw shiitake mushrooms or standard shiitake extracts.
AHCC vs Other Mushroom Extracts
The UK supplement market includes numerous mushroom-based products — lion's mane, reishi, cordyceps, chaga, maitake, and turkey tail are among the most common. Understanding where AHCC sits within this landscape is useful for anyone comparing options.
| Factor | AHCC® | Other Mushroom Extracts |
|---|---|---|
| Source material | Cultured shiitake mycelia only | Fruiting body, mycelium, or both |
| Polysaccharide type | Alpha-glucans (low molecular weight) | Beta-glucans (high molecular weight) |
| Molecular weight | ~5,000 Daltons | 100,000–500,000 Daltons |
| Human clinical studies | 30+ published | Varies — growing but generally fewer |
| Standardisation | Single manufacturer (Amino Up) | Multiple manufacturers, quality varies |
| Trademark | AHCC® trademarked | Generally not trademarked |
What Does the Research Say?
AHCC has been studied in a range of contexts. The following is a factual summary of where research has been conducted. This section describes published research and does not constitute health claims or medical advice.
🔬 Immunological Research
The majority of AHCC research has focused on its effects on various immune cell populations. Published studies have examined its effects on natural killer (NK) cells, T-cells (both CD4+ and CD8+), dendritic cells, and various cytokines. A study in healthy adults reported changes in T-cell immune responses and dendritic cell number and function following AHCC supplementation.
📄 HPV Research
A 2022 double-blind, placebo-controlled clinical study published in Frontiers in Oncology examined AHCC supplementation in women with persistent high-risk HPV infections lasting more than two years. The study enrolled 50 women and administered 3g of AHCC daily for six months. This is currently one of the most-cited AHCC studies and represents the first randomised controlled trial on this specific topic.
🏥 Oncology-Adjacent Research
Several studies have examined AHCC in the context of patients undergoing chemotherapy, looking at parameters such as quality of life assessments, adverse event reporting, and immune cell counts during treatment cycles. A randomised controlled trial in patients with epithelial ovarian cancer examined CD4+ and CD8+ T-cell levels during platinum-based chemotherapy with concurrent AHCC supplementation.
🧪 Additional Research Areas
Liver-related research: Studies in patients with alcohol-related liver injury and chronic hepatitis C have examined liver enzyme levels and inflammatory markers during AHCC supplementation periods.
Influenza vaccine research: A study examined the antibody response to influenza B vaccination in individuals supplementing with AHCC, reporting observations on immune markers following vaccination.
Important context: While the volume of published research on AHCC is substantial compared to most dietary supplements, much of the evidence base consists of small trials, animal studies, and in vitro (laboratory) work. Larger, multi-centre clinical trials would be needed before definitive conclusions can be drawn. AHCC is not a substitute for medical treatment.
AHCC Dosage: What Do Studies Use?
Dosages used in published AHCC research vary, but the most commonly reported protocol in clinical studies is 3 grams (3,000mg) per day, typically divided into multiple doses taken on an empty stomach.
Phase I Safety Trial
High-dose safety assessment in healthy volunteers
9g/day for 14 daysHPV Study (Frontiers in Oncology, 2022)
Double-blind, placebo-controlled trial in women with persistent HPV
3g/day for 6 monthsChemotherapy-Adjacent Studies
Divided as two 500mg capsules three times daily
3g/dayLiver Injury Study
12-week supplementation period
1g–3g/dayMaintenance / General Use
Manufacturer guidance for daily supplementation
1g–3g/dayThese are research protocols and not dosage recommendations. Anyone considering AHCC supplementation should consult a healthcare professional, particularly if taking medication or undergoing medical treatment.
Side Effects and Safety Profile
AHCC has a generally favourable safety profile in published research. The Phase I safety trial administered 9g per day — significantly higher than typical supplementation levels — and reported no significant laboratory abnormalities. The dose was tolerated by 85% of participants.
Reported side effects across studies have been mild and infrequent, including nausea, diarrhoea, bloating, headache, fatigue, and foot cramps. In one study of cancer patients, a single participant experienced a skin reaction (rash and dizziness) which resolved with standard treatment.
⚠️ Safety Not Established For
Pregnant or breastfeeding women, young children, or individuals with severe liver or kidney disease. Individuals with known allergies to mushrooms (particularly basidiomycete species) should avoid AHCC.
Potential Drug Interactions
Published pharmacological research has identified potential interactions between AHCC and certain medications:
⚠️ CYP2D6 Substrates
Research suggests AHCC may induce the CYP2D6 enzyme, involved in the metabolism of various medications including certain chemotherapy drugs (such as doxorubicin) and anti-nausea medications (such as ondansetron). Clinical significance has not been fully established.
⚠️ Aromatase Inhibitors
Research indicates AHCC may induce aromatase activity, which could theoretically reduce the effectiveness of aromatase inhibitor medications (such as letrozole) used in certain cancer treatments. Clinical relevance has not been fully determined.
Anyone taking prescription medication — particularly chemotherapy drugs, hormonal treatments, or medications metabolised by CYP2D6 — should consult their doctor or pharmacist before taking AHCC.
What to Look for When Buying AHCC in the UK
Quality Buying Checklist for AHCC
- Authentic AHCC® with trademark — look for the registered trademark (®) on the label. Generic "shiitake extract" is a different product
- Dosage per serving clearly stated — clinical studies typically use 1g–3g per day. Check the actual AHCC content, not total capsule weight
- Third-party testing — independent certificates of analysis verifying purity, potency, heavy metals, and microbiological safety
- Vegan capsules — pullulan or HPMC capsules for plant-based diets. Check for unnecessary fillers
- UK manufacturing under GMP — additional quality assurance and regulatory compliance
- Complementary nutrients — products with zinc or selenium offer EFSA-authorised immune system claims alongside AHCC
✦ EFSA-Authorised Claims for Complementary Ingredients
- Zinc contributes to the normal function of the immune system
- Selenium contributes to the normal function of the immune system
- Selenium contributes to the protection of cells from oxidative stress
PURETREX AHCC Products
AHCC with Acylated Alpha-Glycans — 750mg Vegicaps
- 1,500mg AHCC per two-capsule serving
- 60 vegan capsules per pouch
- Single-ingredient AHCC — no fillers or additives
- Manufactured in the UK
- Eurofins third-party tested
AHCC+ Mushroom Immune Matrix 10-in-1
- 250mg AHCC + 9 mushroom extracts
- Lion's mane, cordyceps, reishi, chaga, maitake, turkey tail, shiitake (all 10:1)
- Fisetin + BioPerine® for absorption
- Zinc 15mg + Selenium 200mcg (EFSA-authorised immune claims)
- Vegan capsules — no gluten, soy, dairy
- Made in the UK, Eurofins tested
Both products ship same-day before 1PM Mon–Fri / 10AM Sat · Free UK delivery over £60
Frequently Asked Questions